Therapeutic drug development program for COVID-19 : Multicenter Study to evaluate efficacy and safety of Demethylchlortetracycline in Patients of COVID-19 - COVID-DMC

Medienart:

Klinische Studie

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

WHO International Clinical Trials Registry Platform - (2022) vom: 28. Juni Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: COVID-19
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 26-08-2020, Last updated: 2022-11-24

ICTRP ID:

JPRN-jRCTs051200049

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO004551370